Collateral for a security interest recorded Mar 16, 2026 (Wilmington Trust, National Association).
Term ends Nov 25, 2026 · High confidence
20-year base term ended Aug 16, 2024
Held by OptiNose Inc.
Filed Dec 21, 2006 as application 10/568,391 · Granted Aug 31, 2010
Base term plus 831 days of patent term adjustment (USPTO delay)
Today
2004
2026
Clock starts
Aug 16, 2004
Aug 16, 2004
Term ends
Nov 25, 2026
Nov 25, 2026
Granted
Aug 31, 2010
Aug 31, 2010
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
831
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
127
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 831 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 16, 2004, when application PCT/IB2004/002751, the earliest non-provisional in its chain, was filed (this one was filed Dec 21, 2006) | Aug 16, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +831 days, USPTO patent term adjustment record | Nov 25, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 25, 2026 | High confidence |
This family
| US 7,377,901 | Term ended Sep 2021 | Sep 2021 |
| US 8,596,278 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 7,740,014 | Term ended Mar 2024 | Mar 2024 |
| US 7,347,201 | Term ended Jun 2021 | Jun 2021 |
| US 7,543,581 | Lapsed on the fee record Jun 2013 | Jun 2013 |
| US 8,327,844 | Term ended Oct 2023 | Oct 2023 |
| US 7,975,690 | Term ended Dec 2025 | Dec 2025 |
| US 7,841,337 | Term ended no later than Apr 2022 | no later than Apr 2022 |
8 of 127 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 16, 2010 Reel 24245, frame 253 | Djupesland, Per Gisle; Murphy, Martin Joseph; Kay, Stuart Brian William; Pocock, Andrew Gordon | OptiNose As | Assignment of Assignor's Interest |
| Jun 14, 2017 Reel 42703, frame 491 | Djupesland, Per Gisle; Murphy, Martin Joseph; Kay, Stuart Brian William; Pocock, Andrew Gordon | OptiNose As | Assignment of Assignor's Interest |
| Dec 29, 2017 Reel 44976, frame 505 | OptiNose As | Athyrium Opportunities III Acquisition LP | Security Interest |
| Sep 13, 2019 Reel 50371, frame 894 | Athyrium Opportunities III Acquisition LP | OptiNose As | Release of Security Agreement Recorded at Reel 044976 Frame 0505 |
| Sep 13, 2019 Reel 50371, frame 913 | OptiNose As | Biopharma Credit PLC, as Collateral Agent | Security Interest |
| Sep 27, 2022 Reel 61546, frame 424 | OptiNose As | OptiNose Inc. | Assignment of Assignor's Interest |
| Jan 7, 2025 Reel 69833, frame 758 | OptiNose, Inc. | OptiNose, Inc. | Change of Address |
| May 21, 2025 Reel 71547, frame 979 | Biopharma Credit PLC, as Collateral Agent | OptiNose Inc. | Release of Security Interest |
| May 22, 2025 Reel 71337, frame 132 | OptiNose, Inc. | Oaktree Fund Administration, LLC | Security Interest |
| Mar 16, 2026 Reel 75111, frame 18 | OptiNose, Inc. | Wilmington Trust, National Association, as Administrative Agent | Patent Security Agreement |
| Mar 17, 2026 Reel 75101, frame 804 | Oaktree Fund Administration, LLC | OptiNose, Inc. | Release of Security Interest in Patents Recorded at Reel/Frame 71337/0132 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2026
Term ends Nov 25, 2026. No further fees fall due before then
Note
The 831 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
154
later US patents cite this one
That is top 5% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.